zoledronic acid has been researched along with Bone Inflammation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, Y; Kiyama, T; Kuroishi, T; Oizumi, T; Okada, S; Sasaki, K; Sato, E; Sugawara, S; Takahashi, T; Tanaka, Y | 1 |
| Bearcroft, PW; Bhagat, S; Clunie, GP; Garber, SJ; Gaston, JS; Ginawi, A; Grainger, A; O'Conner, P | 1 |
| Cardoso, CL; Cavenago, BC; Curi, MM; Curra, C; Ferreira, O; Matsumoto, MA; Santiago, JF; Santos, PL | 1 |
| Arranz Caso, JA; Dominguez-Mompello, JL; Flores Ballester, E; López Pizarro, V; Ngo Pombe, S; Restoy Lozano, A | 1 |
| Cardemil, C; Norlindh, B; Omar, OM; Thomsen, P; Wexell, CL | 1 |
| Chole, RA; Ebmeyer, J; Faddis, BT; Hildmann, H; Jung, JY; Sudhoff, H | 1 |
| Casas, N; Delmas, PD; Eriksen, EF; Grbic, JT; Hua, Y; Landesberg, R; Leung, PC; Lin, SQ; Mesenbrink, P; Recknor, CP; Reid, IR | 1 |
1 review(s) available for zoledronic acid and Bone Inflammation
| Article | Year |
|---|---|
[Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces].
Topics: Actinomyces; Actinomycosis; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Combined Modality Therapy; Diphosphonates; Disease Susceptibility; Etidronic Acid; Female; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Models, Biological; Neoplasms; Osteitis; Osteoporosis; Retrospective Studies; Risedronic Acid; Zoledronic Acid | 2012 |
2 trial(s) available for zoledronic acid and Bone Inflammation
| Article | Year |
|---|---|
The effects of a systemic single dose of zoledronic acid on post-implantation bone remodelling and inflammation in an ovariectomised rat model.
Topics: Animals; Bone Density Conservation Agents; Combined Modality Therapy; Diphosphonates; Female; Fractures, Bone; Imidazoles; Osteitis; Osteogenesis; Ovariectomy; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Treatment Outcome; Zoledronic Acid | 2013 |
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Epidemiologic Methods; Female; Hip Fractures; Humans; Imidazoles; Jaw Diseases; Middle Aged; Osteitis; Osteomyelitis; Osteonecrosis; Osteoporosis, Postmenopausal; Periapical Abscess; Zoledronic Acid | 2008 |
4 other study(ies) available for zoledronic acid and Bone Inflammation
| Article | Year |
|---|---|
Inhibition of phosphate transporters ameliorates the inflammatory and necrotic side effects of the nitrogen-containing bisphosphonate zoledronate in mice.
Topics: Animals; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Foscarnet; Imidazoles; Mice; Mice, Inbred BALB C; Molecular Structure; Necrosis; Osteitis; Phosphate Transport Proteins; Zoledronic Acid | 2013 |
An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis.
Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Magnetic Resonance Imaging; Male; Middle Aged; Osteitis; Spondylitis, Ankylosing; Treatment Outcome; Zoledronic Acid | 2014 |
Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model.
Topics: Administration, Intravenous; Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Imidazoles; Incisor; Male; Maxillary Diseases; Models, Animal; Osteitis; Osteolysis; Rats, Wistar; Tooth Extraction; X-Ray Microtomography; Zoledronic Acid | 2016 |
Zoledronic acid inhibits osteoclastogenesis in vitro and in a mouse model of inflammatory osteolysis.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Cell Division; Cells, Cultured; Diphosphonates; Dose-Response Relationship, Drug; Imidazoles; Injections, Subcutaneous; Keratins; Male; Mice; Mice, Inbred C57BL; Minerals; Osteitis; Osteoclasts; Osteolysis; Parietal Bone; Periosteum; Prostheses and Implants; Skull; Zoledronic Acid | 2003 |